National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Johannes A Langendijk; Frank J P Hoebers; Martin A de Jong; Patricia Doornaert; Chris H J Terhaard; Roel J H M Steenbakkers; Olga Hamming-Vrieze; Jeroen B van de Kamer; Wilko F A R Verbakel; Fatma Keskin-Cambay; Johannes B Reitsma; Arjen van der Schaaf; Liesbeth J Boersma; Ewoud Schuit

doi:10.14338/IJPT-20-00089.1

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Johannes A Langendijk
, Frank J P Hoebers
, Martin A de Jong
, Patricia Doornaert
, Chris H J Terhaard
, Roel J H M Steenbakkers
, Olga Hamming-Vrieze
, Jeroen B van de Kamer
, Wilko F A R Verbakel
, Fatma Keskin-Cambay
, Johannes B Reitsma
, Arjen van der Schaaf
, Liesbeth J Boersma
, Ewoud Schuit

Research output: Contribution to journal › Article › Academic › peer-review

6 Downloads (Pure)

Abstract

In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

Original language	English
Pages (from-to)	354-365
Number of pages	12
Journal	International journal of particle therapy
Volume	8
Issue number	1
DOIs	https://doi.org/10.14338/IJPT-20-00089.1
Publication status	Published - 1 Jun 2021

Keywords

head and neck cancer
model-based selection
national indication protocol
proton therapy
radiation-induced side effects
Radiation-induced side effects
Model-based selection
National indication protocol
Head and neck cancer
Proton therapy

Access to Document

10.14338/IJPT-20-00089.1

i2331-5180-8-1-354Final published version, 1.05 MB

Cite this

Langendijk, J. A., Hoebers, F. J. P., de Jong, M. A., Doornaert, P., Terhaard, C. H. J., Steenbakkers, R. J. H. M., Hamming-Vrieze, O., van de Kamer, J. B., Verbakel, W. F. A. R., Keskin-Cambay, F., Reitsma, J. B., van der Schaaf, A., Boersma, L. J., & Schuit, E. (2021). National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer. International journal of particle therapy, 8(1), 354-365. https://doi.org/10.14338/IJPT-20-00089.1

@article{c411120f8c7b4564b3c3d1fe9138f530,

title = "National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer",

abstract = "In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.",

keywords = "head and neck cancer, model-based selection, national indication protocol, proton therapy, radiation-induced side effects, Radiation-induced side effects, Model-based selection, National indication protocol, Head and neck cancer, Proton therapy",

author = "Langendijk, \{Johannes A\} and Hoebers, \{Frank J P\} and \{de Jong\}, \{Martin A\} and Patricia Doornaert and Terhaard, \{Chris H J\} and Steenbakkers, \{Roel J H M\} and Olga Hamming-Vrieze and \{van de Kamer\}, \{Jeroen B\} and Verbakel, \{Wilko F A R\} and Fatma Keskin-Cambay and Reitsma, \{Johannes B\} and \{van der Schaaf\}, Arjen and Boersma, \{Liesbeth J\} and Ewoud Schuit",

year = "2021",

month = jun,

day = "1",

doi = "10.14338/IJPT-20-00089.1",

language = "English",

volume = "8",

pages = "354--365",

journal = "International journal of particle therapy",

issn = "2331-5180",

publisher = "Elsevier",

number = "1",

}

Langendijk, JA, Hoebers, FJP, de Jong, MA, Doornaert, P, Terhaard, CHJ, Steenbakkers, RJHM, Hamming-Vrieze, O, van de Kamer, JB, Verbakel, WFAR, Keskin-Cambay, F, Reitsma, JB, van der Schaaf, A, Boersma, LJ & Schuit, E 2021, 'National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer', International journal of particle therapy, vol. 8, no. 1, pp. 354-365. https://doi.org/10.14338/IJPT-20-00089.1

TY - JOUR

T1 - National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

AU - Langendijk, Johannes A

AU - Hoebers, Frank J P

AU - de Jong, Martin A

AU - Doornaert, Patricia

AU - Terhaard, Chris H J

AU - Steenbakkers, Roel J H M

AU - Hamming-Vrieze, Olga

AU - van de Kamer, Jeroen B

AU - Verbakel, Wilko F A R

AU - Keskin-Cambay, Fatma

AU - Reitsma, Johannes B

AU - van der Schaaf, Arjen

AU - Boersma, Liesbeth J

AU - Schuit, Ewoud

PY - 2021/6/1

Y1 - 2021/6/1

N2 - In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

AB - In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.

KW - head and neck cancer

KW - model-based selection

KW - national indication protocol

KW - proton therapy

KW - radiation-induced side effects

KW - Radiation-induced side effects

KW - Model-based selection

KW - National indication protocol

KW - Head and neck cancer

KW - Proton therapy

UR - https://www.scopus.com/pages/publications/85115788945

U2 - 10.14338/IJPT-20-00089.1

DO - 10.14338/IJPT-20-00089.1

M3 - Article

C2 - 34285961

SN - 2331-5180

VL - 8

SP - 354

EP - 365

JO - International journal of particle therapy

JF - International journal of particle therapy

IS - 1

ER -

National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this